Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Bread Financial Schedules Third Quarter 2026 Earnings Conference Call for Oct. 22
-
Fingrid Oyj’s Shareholders’ unanimous decision of 5 October 2026
-
Edible Garden Awarded New Walmart Fresh Herb Program for Peak Holiday Season
-
Beeline Expects Q3 2026 Revenue to Reach Highest Level Since 2021, Record Margins, Lower Net Loss and Lowest Adjusted EBITDA Loss in 5 Years
-
First Atlantic Nickel & Cobalt Raises Total of $13.4 Million with Additional $3.49 Million No-Warrant, Non-Brokered Private Placement at $0.83 per Share, a Premium to Market, to Accelerate Explora
-
First Atlantic Nickel & Cobalt Raises Total of $13.4 Million with Additional $3.49 Million No-Warrant, Non-Brokered Private Placement at $0.83 per Share, a Premium to Market, to Accelerate Exploration
-
STARTRADER Adds 20 Stock and ETF CFDs to Its 24/7 Trading Range
-
Zenas BioPharma to Host Virtual R&D Event
-
Zenas BioPharma to Host Virtual R&D Event
-
ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer
-
Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate
-
SNDL Announces Resignation of Director
-
Patagonia Gold Corrects Cost Metrics and Economic Results for the Calcatreu PEA
-
Canterra Minerals Expands Lundberg Indicated Mineral Resource by 55% to 26.1 Mt at the Buchans Project in Newfoundland
-
Kamada Announces Expansion of Biosimilars Portfolio with the Launch of Two Additional Products in Israel
-
Canadian payment transactions total more than $12 trillion in 2025; real-time payments appeal to over half of Canadians: Payments Canada Research
-
Auddia Cancels October 7th Shareholder Meeting to Align Merger Vote with Expanding AI Infrastructure Opportunity
-
Freehand CEO Nitin Jayakrishnan Addresses Supply Chain Disruption and Resilience at LogiPharma USA 2026
-
F2G Announces Abstracts Accepted for Oral and Poster Presentation at IDWeek 2026
-
Simply Good Foods to Report Fourth Quarter Fiscal Year 2026 Financial Results on Tuesday, October 27, 2026
-
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
-
ServiceTitan Announcing New and Expanded Capabilities at Pantheon 2026
-
OKYO Pharma Announces First Patients Enrolled in Phase 3 Pivotal Trial of Urcosimod for Neuropathic Corneal Pain
-
SignWell Partners With TD SYNNEX to Scale Enterprise-Grade eSignature Platform Across Partner Ecosystem
-
InNova Global Fund Opens Reg D 506(c) Offering to Fund Microlending in Kenya
-
Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026
-
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
-
Shopify to Announce Third-Quarter 2026 Financial Results
-
Xanadu and GlobalFoundries Announce Strategic Partnership to Accelerate Utility-Scale Quantum Manufacturing
-
Gumption Releases Q3 2026 CRE Lending Report: New Term Sheet Data From 700+ Lenders Finds Floating CRE Rates Are Now Cheaper Than Fixed
-
Timothy Partners, Ltd. Names Brian Mumbert CEO
-
LiveU and Airwise Announce Strategic Partnership to Deliver End-to-End Solution for Public Safety Situational Awareness
-
Octave to Report Third Quarter 2026 Financial Results on November 12
-
YieldMax® ETFs Announces Weekly Distributions for Group 1 ETFs
-
YieldMax® ETFs Announces Distributions on BIGY, RNTY and SOXY
-
CTO Realty Growth Announces Acquisition of Summit Woods Crossing for $103.0 Million
-
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
-
Bullish releases September 2026 monthly metrics
-
Descartes Unveils Next Step in Supply Chain AI with Agent Control Plane
-
Final results of Martela Corporation’s directed share issue
-
Nox Peptides Announces Launch of GHK-Cu and Wolverine Stack for Canadian Research Market
-
GTC Prime Partners with Centroid Solutions to Deliver Multi-Asset Liquidity via CS 360 Bridge
-
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
-
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
-
Range Announces Conference Call to Discuss Third Quarter 2026 Financial Results
-
Bimergen Energy Co-CEO Joins Featured Keynote Panel at MoneyShow; Highlights 2026 Milestones in Company Presentations
-
Parsons to Announce Third-Quarter 2026 Financial Results on October 28, 2026
-
Form 8.5 (EPT/RI)-Tribal Group Plc
-
ISS implements a new share-based incentive programme
-
Trial Lawyer Fraud Ring Accusations Exposed
